22 results
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
31 May 23
THE NEXT EVOLUTION IN CELLULAR MEDICINE Investor Presentation June 2023
5:08pm
need at unparalleled scale, quality and economics Mission Statement
CELULARITY: COMPANY HISTORY Celgene Spin-out (2017) Leveraging 20+ Years of Cellular
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
10 Nov 22
Celularity Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:19pm
commercial biomaterials products. As we work to fulfill our mission to positively impact patients’ lives with placental-derived therapeutic solutions, we have … statements in this press release include statements regarding Celularity’s ability to address cancer and degenerative diseases and fulfill its mission
424B3
CELU
Celularity Inc - Ordinary Shares
1 Jun 22
Prospectus supplement
4:06pm
patients throughout the world. We plan to achieve this mission by:
Leveraging the inherent advantages of placental-derived cells. Our cells come from
424B3
lcv gwgb1uouvs
3 May 22
Prospectus supplement
4:06pm
POS AM
glcjk8k 5i0lmx3h
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
8-K
EX-99.1
o6dzc9da
31 Mar 22
Celularity Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:06pm
424B3
ixajhb6iq qzxf0fp88
12 Aug 21
Prospectus supplement
4:21pm
425
7k84iwe4v1vod
7 Jul 21
Business combination disclosure
4:11pm
425
sz3mkgncyfq 30yqto
1 Jul 21
Business combination disclosure
5:09pm
8-K
EX-99.1
3usivk bjrhrg86v
1 Jul 21
Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products
5:07pm
S-4/A
g29ew
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4
EX-10.32
g2bigv5xoew07fm1
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
967exhp8dts1
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm